SBN: Proposed Investment in OMI
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Dimerix
- Update on EP 389 Farmin
- SBN: Convertible Note Agreement
- Non-Renounceable Rights Issue Announcement and Appendix 3B
- Half Year Accounts
- Consolidation Announcement and Notice of General Meeting
Later from Dimerix
- Activity Report & Appendix 4C
- Dimerix Receives TGA Special Access Scheme Approval
- DXB requests US FDA pre IND meeting - performance milestone
- ARC Linkage Grant to progress discovery platform
- 10 Patient Milestone Reached. On Track to Report Trial Data.
Follow Dimerix into a list and get an email when it puts out news.
Follow Dimerix